Clínica de Pesquisa e Centro de Estudos em Ginecologia Oncológica e Mamária LTDA

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Eli Lilly and Company2 trials

Running trials

• Active, not recruiting

  A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

  NCT04975308· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

  NCT02763566· Phase 3· Eli Lilly and Company· Source